Every day, healthcare leaders are inundated with pitches from AI companies promising to transform their operations and patient experience. But which ones are actually worth pursuing? In this episode of Cedar Talks, our Head of Commercial Strategy Dugan Winkie sits down with Nworah Ayogu, MD from Thrive Capital to cut through the noise. Drawing from his experience as both a physician and investor, Dr. Ayogu breaks down how he evaluates healthcare AI startups, what problems are actually ripe for AI solutions, and where he sees real potential for impact in the coming years.
Watch the full episode
Conversation highlights
The AI hype is different
AI skeptics, take note: Dr. Ayogu explains why the technology is unlike anything the healthcare industry has seen before.
Beyond the buzzwords
As a tech investor vetting today’s most promising AI healthcare solutions, Dr. Ayogu shares his first crucial test.
When AI shows cracks
This often overlooked red flag helps Dr. Ayogu spot which AI healthcare solutions aren’t quite ready for prime time.
Ben Kraus is Senior Content Lead at Cedar
